{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:18:57Z","timestamp":1791551937420,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.yrtph.2010.05.008","type":"journal-article","created":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T08:21:40Z","timestamp":1274775700000},"page":"196-207","source":"Crossref","is-referenced-by-count":7,"title":["Twenty-eight days repeated oral dose toxicity study of gemifloxacin in Wistar albino rats"],"prefix":"10.1016","volume":"58","author":[{"given":"Bikash","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan Kanti","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2010.05.008_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.45.2.540-545.2001","article-title":"Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers","volume":"45","author":"Allen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.yrtph.2010.05.008_bib2","first-page":"406","article-title":"Ultrastructural changes of the gemifloxacin on Achilles tendon in immature rats: comparison with those of ciproxacin and ofloxacin","volume":"98","author":"Bae","year":"2006","journal-title":"BCPT"},{"key":"10.1016\/j.yrtph.2010.05.008_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.jac.a020889","article-title":"Quinolone generations: natural history or natural selection?","volume":"46","author":"Ball","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. S1","key":"10.1016\/j.yrtph.2010.05.008_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkg209","article-title":"Adverse drug reactions: implications for the development of fluroquinolones","volume":"51","author":"Ball","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/45.suppl_3.79","article-title":"Comparative efficacy of gemifloxacin in a rat model of respiratory tract infection","volume":"45","author":"Berry","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pupt.2005.09.008","article-title":"Highlights on the appropriate use of fluroquinolones in respiratory tract infections","volume":"19","author":"Blasi","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2010.05.008_bib7","series-title":"Pathology of the Fischer Rat. Reference and Atlas","author":"Boorman","year":"1990"},{"key":"10.1016\/j.yrtph.2010.05.008_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/AAC.41.1.204","article-title":"Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone","volume":"41","author":"Cormican","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1351\/pac199365092003","article-title":"World Health Organization, Geneva, 1979, Agreed terms on health effects evaluation and risk and hazard assessment of environmental agents. Internal report of a working group, (EHE\/EHC\/79.19) in glossary for chemists of terms used in toxicology","volume":"65","author":"Duffus","year":"1993","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.yrtph.2010.05.008_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Eliseo","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yrtph.2010.05.008_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/JCM.37.1.279-280.1999","article-title":"Studies to establish quality control ranges for SB-265805 (LB20304) when using antimicrobial susceptibility test methods. Quality control study group","volume":"37","author":"Erwin","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.yrtph.2010.05.008_bib12","series-title":"Histopathology of Preclinical Studies: Interpretation and Relevance in Drug Evaluation","author":"Greaves","year":"1990"},{"key":"10.1016\/j.yrtph.2010.05.008_bib13","first-page":"485","article-title":"Subchronic toxicity of the new quinolone antibacterial agent irloxacin in Beagle dogs","volume":"50","author":"Guzman","year":"2000","journal-title":"Arzneim.-Forsch.\/Drug Res."},{"key":"10.1016\/j.yrtph.2010.05.008_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/45.3.367","article-title":"In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas","volume":"45","author":"Hannan","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib15","series-title":"Fundamentals of Toxicologic Pathology","author":"Haschek","year":"1998"},{"issue":"3","key":"10.1016\/j.yrtph.2010.05.008_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/AAC.48.3.799-803.2004","article-title":"New findings on the structure\u2013phototoxicity relationship and photostability of fluoroquinolones with various substituents at position 1","volume":"48","author":"Hayashi","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.28.5.716","article-title":"The fluoroquinolones: pharmacology, clinical uses, and toxicities in human","volume":"28","author":"Hooper","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.29.6.1073","article-title":"Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase a primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts","volume":"29","author":"Hussy","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0732-8893(98)00104-7","article-title":"Anti-streptococcal activity of SB-265805 (LB20304) a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines","volume":"33","author":"Johnson","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.yrtph.2010.05.008_bib20","first-page":"141","article-title":"Reference values of hematology and serum chemistry in Ktc: Sprague\u2013Dawley rats","volume":"11","author":"Kang","year":"1995","journal-title":"Kor. J. Anim. Sci."},{"key":"10.1016\/j.yrtph.2010.05.008_bib21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0278-6915(02)00152-7","article-title":"Subchronic toxicity of plant sterol esters administered by gavage to Sprague\u2013Dawley rats","volume":"40","author":"Kim","year":"2002","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2010.05.008_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.fct.2007.08.044","article-title":"Sixty-day repeated dose toxicity of sinafloxacin in rat and dogs","volume":"46","author":"Lu","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2010.05.008_bib23","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/AAC.37.10.2217","article-title":"Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light","volume":"37","author":"Marutani","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib24","unstructured":"OECD (Organization for Economic Co-operation and Development), 1995. Guideline for the Testing of Chemicals. Guideline 407: Repeated Dose 28-Day Oral Toxicity Study in Rodents (Adopted 27.07.1995)."},{"key":"10.1016\/j.yrtph.2010.05.008_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.1968.03140070064014","article-title":"Compensated polarized light microscopy. Identification of crystals in synovial fluids from gout and pseudogout","volume":"203","author":"Phelps","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.yrtph.2010.05.008_bib26","first-page":"435","article-title":"The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs","volume":"29","author":"Ramji","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2010.05.008_bib27","first-page":"133","article-title":"Adverse effects of fluoroquinolones","volume":"38","author":"Shimada","year":"1992","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.yrtph.2010.05.008_bib28","unstructured":"US Food and Drug Administration, 1978. Good laboratory practice Regulations 21 CFR Part 58. Federal Register 22 December 1979 and subsequent amendments."},{"issue":"Suppl. B","key":"10.1016\/j.yrtph.2010.05.008_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/43.suppl_2.91","article-title":"Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone","volume":"43","author":"von Keutz","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.yrtph.2010.05.008_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000007246","article-title":"Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin","volume":"45","author":"Vousden","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.yrtph.2010.05.008_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-4274(91)90176-7","article-title":"Quinolone antibacterial-agent-induced cutaneous phototoxicity: ear swelling reactions in Balb\/c mice","volume":"58","author":"Wagai","year":"1991","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2010.05.008_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-4274(90)90197-T","article-title":"Phototoxic potential of quinolone antibacterial agents in Balb\/c mice","volume":"54","author":"Wagai","year":"1990","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2010.05.008_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/15287398609530859","article-title":"Reference range data base for serum chemistry and hematology values in laboratory animals","volume":"18","author":"Wolford","year":"1986","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.yrtph.2010.05.008_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/46.5.669","article-title":"Application of fluroquinolone pharmacodynamics","volume":"46","author":"Wright","year":"2000","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230010000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230010000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:39:24Z","timestamp":1591317564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230010000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0273230010000887"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2010.05.008","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}